Xylazine

Basic Information

Item Value
DrugBank ID DB11477
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 migraine disorder KG + DL
2 open-angle glaucoma KG + DL
3 migraine with brainstem aura KG + DL
4 primary hereditary glaucoma KG + DL
5 migraine with or without aura, susceptibility to KG + DL
6 atrophoderma vermiculata KG + DL
7 postural orthostatic tachycardia syndrome KG + DL
8 ulerythema ophryogenesis KG + DL
9 glaucoma 1, open angle KG + DL
10 congenital hypotrichosis milia KG + DL
11 manic bipolar affective disorder KG + DL
12 diffuse alopecia areata KG + DL
13 multiple system atrophy KG + DL
14 hypotrichosis simplex of the scalp KG + DL
15 alopecia KG + DL
16 headache disorder KG + DL
17 Raynaud disease KG + DL
18 variably protease-sensitive prionopathy KG + DL
19 pulmonary hypertension KG + DL
20 vascular disease KG + DL
21 sinoatrial block KG + DL
22 arterial thoracic outlet syndrome KG + DL
23 venous thoracic outlet syndrome KG + DL
24 trigeminal autonomic cephalalgia KG + DL
25 idiopathic spontaneous coronary artery dissection KG + DL
26 sciatic neuropathy KG + DL
27 sinoatrial node disease KG + DL
28 neurogenic thoracic outlet syndrome KG + DL
29 visceral calciphylaxis KG + DL
30 anaphylaxis KG + DL
31 open angle glaucoma KG + DL
32 hemangioendothelioma KG + DL
33 blue toe syndrome KG + DL
34 kyphoscoliotic heart disease KG + DL
35 angiodysplasia of stomach KG + DL
36 lymphangiectasis KG + DL
37 food-dependent exercise-induced anaphylaxis KG + DL
38 allergic asthma KG + DL
39 arterial dissection-lentiginosis syndrome KG + DL
40 atheroembolism of kidney KG + DL
41 obesity disorder KG + DL
42 transient ischemic attack (disease) KG + DL
43 intrinsic asthma KG + DL
44 dysthymic disorder KG + DL
45 nephrogenic syndrome of inappropriate antidiuresis KG + DL
46 asthma-related traits, susceptibility to KG + DL
47 monogenic obesity KG + DL
48 bronchial disease KG + DL
49 pulmonary hypertension, primary, autosomal recessive KG + DL
50 hypervitaminosis KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.